ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Design Therapeutics Inc

Design Therapeutics Inc (DSGN)

4.36
0.12
(2.83%)
Closed July 14 4:00PM
4.36
0.00
(0.00%)
After Hours: 5:32PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
4.36
Bid
0.4506
Ask
6.00
Volume
210,495
4.27 Day's Range 4.56
1.94 52 Week Range 8.31
Market Cap
Previous Close
4.24
Open
4.32
Last Trade Time
Financial Volume
$ 930,913
VWAP
4.4225
Average Volume (3m)
217,741
Shares Outstanding
56,495,039
Dividend Yield
-
PE Ratio
-3.68
Earnings Per Share (EPS)
-1.18
Revenue
-
Net Profit
-66.86M

About Design Therapeutics Inc

Design Therapeutics Inc is a preclinical-stage biopharmaceutical company. It is a pioneering novel small-molecule therapeutic candidate, called gene-targeted chimera, that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases. Design Therapeutics Inc is a preclinical-stage biopharmaceutical company. It is a pioneering novel small-molecule therapeutic candidate, called gene-targeted chimera, that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
Design Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker DSGN. The last closing price for Design Therapeutics was $4.24. Over the last year, Design Therapeutics shares have traded in a share price range of $ 1.94 to $ 8.31.

Design Therapeutics currently has 56,495,039 shares outstanding. The market capitalization of Design Therapeutics is $239.54 million. Design Therapeutics has a price to earnings ratio (PE ratio) of -3.68.

DSGN Latest News

Design Therapeutics Announces First Quarter 2024 Financial Results and Highlights Upcoming Program Milestones

Advancing DT-216P2, New Drug Product for Friedreich Ataxia (FA), Toward Clinical Trials Starting Phase 1 Development for Fuchs Endothelial Corneal Dystrophy (FECD) in 2024; Observational Study...

Design Therapeutics to Participate in the 2024 RBC Capital Markets Global Healthcare Conference

CARLSBAD, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a biotechnology company developing treatments for serious degenerative genetic diseases, today...

Design Therapeutics Outlines Progress Across GeneTAC™ Platform and Announces Fourth Quarter and Full Year 2023 Financial Results

New Drug Product for Friedreich Ataxia (FA) DT-216P2 with Favorable Nonclinical Pharmacokinetic and Injection Site Safety Profile; Complete GLP Studies by Year-end 2024 to Start Patient Trials in...

US Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices Retreat

In Tuesday’s pre-market trading, U.S. index futures are pointing to a decline, reflecting investors’ caution as they analyze revelations from Nvidia’s artificial intelligence...

Design Therapeutics to Webcast Fourth Quarter and Full Year 2023 Financial Results and Comprehensive Portfolio Update

CARLSBAD, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a biotechnology company developing treatments for serious degenerative genetic diseases, today...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.1937.53943217673.174.563.15938093.82043305CS
40.5815.34391534393.784.563.151612413.43405965CS
120.6417.20430107533.725.233.152177414.07036901CS
261.9177.95918367352.455.232.2452433643.49593796CS
52-2.4-35.50295857996.768.311.944623002.79735231CS
156-14.16-76.457883369318.5226.31.943313927.73166568CS
260-23.64-84.428571428628501.943187448.71100772CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VEVVicinity Motor Corporation
$ 0.7131
(122.15%)
116.26M
QLGNQualigen Therapeutics Inc
$ 0.428851
(108.89%)
420.2M
IVPInspire Veterinary Partners Inc
$ 10.52
(88.19%)
41.79M
TOYOTOYO Company Ltd
$ 2.699
(74.13%)
56.65M
NISNNiSun International Enterprise Development Group Company Ltd
$ 9.11
(51.33%)
7.4M
SISIShineco Inc
$ 0.8446
(-60.16%)
6.71M
MCACMonterey Capital Acquisition Corporation
$ 3.54
(-49.50%)
364.7k
MCACUMonterey Capital Acquisition Corporation
$ 7.64
(-28.40%)
2.61k
GENEGenetic Technologies Ltd
$ 0.80
(-27.93%)
780.46k
KZIAKazia Therapeutics Ltd
$ 0.8975
(-27.62%)
25.62M
QLGNQualigen Therapeutics Inc
$ 0.428851
(108.89%)
420.2M
MAXNMaxeon Solar Technologies Ltd
$ 0.237
(-1.54%)
286.13M
NVDANVIDIA Corporation
$ 129.24
(1.44%)
251.69M
AGRIAgriFORCE Growing Systems Ltd
$ 0.1001
(21.92%)
192.82M
LCIDLucid Group Inc
$ 4.25
(25.00%)
167.79M

Your Recent History

Delayed Upgrade Clock